Manuela Cesaretti

Manuela Cesaretti

Auto-generated profile, based on publicly available information

Manuela Cesaretti

HPB and Liver Transplantation Department, ARNAS Brotzu, Cagliari, Italy

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2016 in Hepatology
Verified
Journal Article
Open access
PDF file
GSGonzalo Sapisochin
Gonzalo Sapisochin
MFM. Facciuto
M. Facciuto
LRL. Rubbia‐Brandt
L. Rubbia‐Brandt
JMJ. Marti
J. Marti
NMN. Mehta
N. Mehta
OCon behalf of the iCCA International Consortium
on behalf of the iCCA International Consortium
The presence of an intrahepatic cholangiocarcinoma (iCCA) in a cirrhotic liver is a contraindication for liver transplantation in most centers worldwide. Recent investigations have shown that “very early” iCCA (single tumors ≤2 cm) may have acceptable results after liver transplantation. This study further evaluates this finding in a larger international multicenter cohort. The study group was composed of those patients who were transplanted for hepatocellular carcinoma or decompensated cirrhosis and found to have an iCCA at explant pathology. Patients were divided into those with “very early” iCCA and those with “advanced” disease (single tumor >2 cm or multifocal disease). Between January 2000 and December 2013, 81 patients were found to have an iCCA at explant; 33 had separate nodules of iCCA and hepatocellular carcinoma, and 48 had only iCCA (study group). Within the study group, 15/48 (31%) constituted the “very early” iCCA group and 33/48 (69%) the “advanced” group. There were no significant differences between groups in preoperative characteristics. At explant, the median size of the largest tumor was larger in the “advanced” group (3.1 [2.5‐4.4] versus 1.6 [1.5‐1.8]). After a median follow‐up of 35 (13.5‐76.4) months, the 1‐year, 3‐year, and 5‐year cumulative risks of recurrence were, respectively, 7%, 18%, and 18% in the very early iCCA group versus 30%, 47%, and 61% in the advanced iCCA group, P = 0.01. The 1‐year, 3‐year, and 5‐year actuarial survival rates were, respectively, 93%, 84%, and 65% in the very early iCCA group versus 79%, 50%, and 45% in the advanced iCCA group, P = 0.02. Conclusion: Patients with cirrhosis and very early iCCA may become candidates for liver transplantation; a prospective multicenter clinical trial is needed to further confirm these results. (Hepatology 2016;64:1178‐1188)

19 May 2020 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
MCManuela Cesaretti
Manuela Cesaretti
RBRaffaele Brustia
Raffaele Brustia
CGClaire Goumard
Claire Goumard
FCFrançois Cauchy
François Cauchy
Nicolas potéNicolas poté
Nicolas poté
Sara MocciaSara Moccia
Sara Moccia

31 October 2018 in Liver Transplantation
Verified
Journal Article
Closed access
PDF file
MCManuela Cesaretti
Manuela Cesaretti
PAPietro Addeo
Pietro Addeo
LSLuigi Schiavo
Luigi Schiavo
RARodolphe Anty
Rodolphe Anty
Antonio IannelliAntonio Iannelli
Antonio Iannelli

23 May 2018 in International Journal of Computer Assisted Radiology and Surgery
Verified
Journal Article
Closed access
PDF file
Sara MocciaSara Moccia
Sara Moccia
Leonardo S. MattosLeonardo S. Mattos
Leonardo S. Mattos
IPIlaria Patrini
Ilaria Patrini
MRMichela Ruperti
Michela Ruperti
NPNicolas Poté
Nicolas Poté
MCManuela Cesaretti
Manuela Cesaretti

26 January 2016 in European Radiology
Verified
Journal Article
Closed access
PDF file
EPEdwige Pottier
Edwige Pottier
Maxime RonotMaxime Ronot
Maxime Ronot
SGSebastien Gaujoux
Sebastien Gaujoux
MCManuela Cesaretti
Manuela Cesaretti
LBLouise Barbier
Louise Barbier
VVValérie Vilgrain
Valérie Vilgrain

1 June 2016 in Journal of Visceral Surgery
Verified
Journal Article
Closed access
MCM. Cesaretti
M. Cesaretti
MAM. Abdel-Rehim
M. Abdel-Rehim
LBL. Barbier
L. Barbier
SDS. Dokmak
S. Dokmak
PHPascal Hammel
Pascal Hammel
SASauvanet Alain
Sauvanet Alain